董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Roy Golan | 男 | Independent Director | 51 | 2.26万美元 | 1.50 | 2026-07-21 |
| Guy Zimmerman | 男 | Independent Director | 56 | 2.88万美元 | 1.75 | 2026-07-21 |
| Ronen Luzon | 男 | Chief Executive Officer and Director | 55 | 54.33万美元 | 36.28 | 2026-07-21 |
| Oron Branitzky | 男 | Independent Director | 66 | 1.53万美元 | 1.75 | 2026-07-21 |
| Arik Kaufman | 男 | Independent Director | 44 | 3.07万美元 | 1.75 | 2026-07-21 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Ronen Luzon | 男 | Chief Executive Officer and Director | 55 | 54.33万美元 | 36.28 | 2026-07-21 |
| Billy Pardo | 女 | Chief Operating Officer and Chief Product Officer | 50 | 24.75万美元 | 7.88 | 2026-07-21 |
| Oren Elmaliah | 男 | Chief Financial Officer | 42 | 18.16万美元 | 3.25 | 2026-07-21 |
| Borja Cembrero Saralegui | 男 | Chief Growth Officer | 34 | 24.38万美元 | 12.08 | 2026-07-21 |
董事简历
中英对照 | 中文 | 英文- Roy Golan
-
Roy Golan，自2025年3月起担任My Size, Inc.旗下公司Size，Inc.旗下公司Size，Inc.董事会成员。他自2024年7月起担任财务顾问，目前还自2025年3月起担任LiveKidney.Bio的首席财务官，并自2024年7月起担任纳斯达克上市公司NeuroSense Therapeutics Ltd.（NASDAQ：NRSN）的董事，该公司开发严重神经退行性疾病的治疗方法。Golan先生此前曾担任Ayala Pharmaceuticals, Inc.（OTCQX：ADXS）的首席财务官，该公司是一家临床阶段的肿瘤学公司，该公司于2023年10月与BioSight Ltd.合并，后者是一家开发血液恶性肿瘤和疾病创新疗法的私营制药公司，直至2024年6月。2019年至2023年，Golan先生担任BioSight Ltd.的执行副总裁兼首席财务官。2018年至2019年，Golan先生担任Exalenz Bioscience Ltd.（TASE：EXEN）的总裁兼首席财务官，该公司是一家特拉维夫证券交易所上市的全球性商业阶段诊断公司，开发了其BreathID技术平台，通过在胃肠病学和肝病学领域提供基于呼吸的测试来改善患者护理，后被Meridian Bioscience, Inc.（纳斯达克股票代码：VIVO）收购。从2015年到2018年，Golan先生通过首次公开募股在NeuroDerm（NASDAQ：NDRM）担任首席财务官，该公司是一家在纳斯达克上市的临床阶段制药公司，开发针对中枢神经系统疾病的下一代药物-设备组合，直至被Mitsubishi Tanabe Pharma Group Company收购，在此之前他曾担任其财务副总裁。Golan先生拥有Bar Ilan大学的法学硕士学位以及Rishon LeZion管理学院的学士学位，同时也是一名持牌注册会计师。
Roy Golan has served as a member of board of directors since July 2024. He has acted as an independent financial advisor since July 2024 and currently serves as a director of Neurosense Therapeutics Ltd.'s Size, Inc. (NASDAQ: MYSZ), a Nasdaq listed company and omnichannel e commerce platform and provider of AI driven software as service measurement solutions for fashion ecommerce companies. Mr. Golan previously served as the Chief Financial Officer of Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical stage oncology company, from its merger with BioSight Ltd., a private pharmaceutical company developing innovative therapeutics for hematological malignancies and disorders, in October 2023 until June 2024. From 2019 to 2023, Mr. Golan served as Executive VP and Chief Financial Officer of BioSight Ltd. From 2018 to 2019, Mr. Golan served as President and Chief Financial Officer of Exalenz Bioscience Ltd. (TASE: EXEN), a Tel Aviv Stock Exchange listed global, commercial stage diagnostics company which developed its BreathID technology platform to improve patient care by providing breath based tests in the fields of gastroenterology and hepatology and was later acquired by Meridian Bioscience, Inc. (NASDAQ: VIVO). From 2015 to 2018, Mr. Golan served as the Chief Financial Officer of NeuroDerm (NASDAQ: NDRM), a Nasdaq listed clinical stage pharmaceutical company developing next generation drug device combinations for central nervous system disorders, through its initial public offering until its acquisition by Mitsubishi Tanabe Pharma Group Company, and prior thereto he served as their VP Finance. Mr. Golan holds an LLM from Bar Ilan University as well as a BA from The College of Management in Rishon LeZion and is also a licensed CPA. - Roy Golan，自2025年3月起担任My Size, Inc.旗下公司Size，Inc.旗下公司Size，Inc.董事会成员。他自2024年7月起担任财务顾问，目前还自2025年3月起担任LiveKidney.Bio的首席财务官，并自2024年7月起担任纳斯达克上市公司NeuroSense Therapeutics Ltd.（NASDAQ：NRSN）的董事，该公司开发严重神经退行性疾病的治疗方法。Golan先生此前曾担任Ayala Pharmaceuticals, Inc.（OTCQX：ADXS）的首席财务官，该公司是一家临床阶段的肿瘤学公司，该公司于2023年10月与BioSight Ltd.合并，后者是一家开发血液恶性肿瘤和疾病创新疗法的私营制药公司，直至2024年6月。2019年至2023年，Golan先生担任BioSight Ltd.的执行副总裁兼首席财务官。2018年至2019年，Golan先生担任Exalenz Bioscience Ltd.（TASE：EXEN）的总裁兼首席财务官，该公司是一家特拉维夫证券交易所上市的全球性商业阶段诊断公司，开发了其BreathID技术平台，通过在胃肠病学和肝病学领域提供基于呼吸的测试来改善患者护理，后被Meridian Bioscience, Inc.（纳斯达克股票代码：VIVO）收购。从2015年到2018年，Golan先生通过首次公开募股在NeuroDerm（NASDAQ：NDRM）担任首席财务官，该公司是一家在纳斯达克上市的临床阶段制药公司，开发针对中枢神经系统疾病的下一代药物-设备组合，直至被Mitsubishi Tanabe Pharma Group Company收购，在此之前他曾担任其财务副总裁。Golan先生拥有Bar Ilan大学的法学硕士学位以及Rishon LeZion管理学院的学士学位，同时也是一名持牌注册会计师。
- Roy Golan has served as a member of board of directors since July 2024. He has acted as an independent financial advisor since July 2024 and currently serves as a director of Neurosense Therapeutics Ltd.'s Size, Inc. (NASDAQ: MYSZ), a Nasdaq listed company and omnichannel e commerce platform and provider of AI driven software as service measurement solutions for fashion ecommerce companies. Mr. Golan previously served as the Chief Financial Officer of Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical stage oncology company, from its merger with BioSight Ltd., a private pharmaceutical company developing innovative therapeutics for hematological malignancies and disorders, in October 2023 until June 2024. From 2019 to 2023, Mr. Golan served as Executive VP and Chief Financial Officer of BioSight Ltd. From 2018 to 2019, Mr. Golan served as President and Chief Financial Officer of Exalenz Bioscience Ltd. (TASE: EXEN), a Tel Aviv Stock Exchange listed global, commercial stage diagnostics company which developed its BreathID technology platform to improve patient care by providing breath based tests in the fields of gastroenterology and hepatology and was later acquired by Meridian Bioscience, Inc. (NASDAQ: VIVO). From 2015 to 2018, Mr. Golan served as the Chief Financial Officer of NeuroDerm (NASDAQ: NDRM), a Nasdaq listed clinical stage pharmaceutical company developing next generation drug device combinations for central nervous system disorders, through its initial public offering until its acquisition by Mitsubishi Tanabe Pharma Group Company, and prior thereto he served as their VP Finance. Mr. Golan holds an LLM from Bar Ilan University as well as a BA from The College of Management in Rishon LeZion and is also a licensed CPA.
- Guy Zimmerman
-
Guy Zimmerman，自2021年8月起担任My Size董事会成员。自2023年11月起，Zimmerman先生担任XJet 3D的首席执行官，自2022年8月起担任首席营销官。此前，Zimmerman先生自2021年2月起担任在线b2B工程市场ManuFuture的创始人兼首席执行官。在此之前的2017年至2021年，Zimmerman先生担任多家科技初创企业的顾问，并且是一家商务旅行在线平台的创始合伙人。2013年至2017年，Zimmerman先生担任Kornit数码市场营销和业务发展执行副总裁，并担任IPO领导层的一员。在此之前，Zimmerman先生曾在Tefron Ltd.担任全球销售和业务发展副总裁，Tefron Ltd.是一家无缝服装技术提供商，在那里他领导了这家价值1亿美元的销售和销售支持组织，为全球零售和时尚品牌提供服务。在此之前，他曾在以色列最大的食品制造商Tnuva集团担任战略和业务发展副总裁，并在麦肯锡公司工作了八年。Zimmerman先生此前曾领导一家可操作的医疗保健管理系统领域的软件初创公司。Zimmerman先生拥有以色列特拉维夫大学工业工程学士学位。
Guy Zimmerman has served as a member of My Size, Inc.'s board of directors since August 2021. Since November 2023, Mr. Zimmerman serves as Chief Executive Officer of XJet 3D having served as Chief Marketing Officer from August 2022. Previously, Mr. Zimmerman served as Founder and CEO of ManuFuture, an online b2b engineering marketplace, since February 2021. Prior to that from 2017 to 2021, Mr. Zimmerman acted as a consultant to several technology start ups and was a founding partner of a business travel online platform. From 2013 to 2017, Mr. Zimmerman served as EVP of Marketing and Business Development of Kornit Digital and was part of the IPO leadership. Prior to that, Mr. Zimmerman served as VP of Global Sales and Business Development at Tefron Ltd., a provider of seamless garment technology, where he led the $100m sales and sales support organization serving global retail and fashion brands. Prior to that he served as Vice President of Strategy and Business Development at Tnuva Group, Israel's largest food manufacturer and spent eight years at McKinsey & Company. Mr. Zimmerman previously led a software startup in the field of operational healthcare management systems. Mr. Zimmerman holds a B.Sc. in Industrial Engineering from Tel Aviv University in Israel. - Guy Zimmerman，自2021年8月起担任My Size董事会成员。自2023年11月起，Zimmerman先生担任XJet 3D的首席执行官，自2022年8月起担任首席营销官。此前，Zimmerman先生自2021年2月起担任在线b2B工程市场ManuFuture的创始人兼首席执行官。在此之前的2017年至2021年，Zimmerman先生担任多家科技初创企业的顾问，并且是一家商务旅行在线平台的创始合伙人。2013年至2017年，Zimmerman先生担任Kornit数码市场营销和业务发展执行副总裁，并担任IPO领导层的一员。在此之前，Zimmerman先生曾在Tefron Ltd.担任全球销售和业务发展副总裁，Tefron Ltd.是一家无缝服装技术提供商，在那里他领导了这家价值1亿美元的销售和销售支持组织，为全球零售和时尚品牌提供服务。在此之前，他曾在以色列最大的食品制造商Tnuva集团担任战略和业务发展副总裁，并在麦肯锡公司工作了八年。Zimmerman先生此前曾领导一家可操作的医疗保健管理系统领域的软件初创公司。Zimmerman先生拥有以色列特拉维夫大学工业工程学士学位。
- Guy Zimmerman has served as a member of My Size, Inc.'s board of directors since August 2021. Since November 2023, Mr. Zimmerman serves as Chief Executive Officer of XJet 3D having served as Chief Marketing Officer from August 2022. Previously, Mr. Zimmerman served as Founder and CEO of ManuFuture, an online b2b engineering marketplace, since February 2021. Prior to that from 2017 to 2021, Mr. Zimmerman acted as a consultant to several technology start ups and was a founding partner of a business travel online platform. From 2013 to 2017, Mr. Zimmerman served as EVP of Marketing and Business Development of Kornit Digital and was part of the IPO leadership. Prior to that, Mr. Zimmerman served as VP of Global Sales and Business Development at Tefron Ltd., a provider of seamless garment technology, where he led the $100m sales and sales support organization serving global retail and fashion brands. Prior to that he served as Vice President of Strategy and Business Development at Tnuva Group, Israel's largest food manufacturer and spent eight years at McKinsey & Company. Mr. Zimmerman previously led a software startup in the field of operational healthcare management systems. Mr. Zimmerman holds a B.Sc. in Industrial Engineering from Tel Aviv University in Israel.
- Ronen Luzon
-
Ronen Luzon，自2013年9月起担任My Size, Inc.，Inc.的首席执行官和My Size，Inc.董事会成员。自2006年以来，Luzon先生还担任Malers Ltd.的首席执行官和创始人，该公司是全球安全解决方案市场的一家公司，为综合通信基础设施、安全和控制系统提供技术解决方案。在加入Malers之前，他曾在多家国际高科技公司担任过包括GA Tech营销副总裁、Eldat Communication专业服务经理等多个高级营销、销售管理和专业服务职位。Luzon先生毕业于伦敦米德尔塞克斯大学，获得IT和商业信息系统学士学位。
Ronen Luzon has served as My Size, Inc.'s Chief Executive Officer and a member of My Size, Inc.'s board of directors since September 2013. Since 2006, Mr. Luzon has additionally served as Chief Executive Officer and founder of Malers Ltd., a company in the global security solutions market which provides technological solutions for integrated communication infrastructures, security and control systems. Prior to Malers, he held several senior marketing, sales management and professional services positions in a variety of international high tech companies including VP marketing of GA Tech and Professional Services Manager of Eldat Communication. Mr. Luzon graduated from Middlesex University in London with a B.S. in IT and Business Information Systems. - Ronen Luzon，自2013年9月起担任My Size, Inc.，Inc.的首席执行官和My Size，Inc.董事会成员。自2006年以来，Luzon先生还担任Malers Ltd.的首席执行官和创始人，该公司是全球安全解决方案市场的一家公司，为综合通信基础设施、安全和控制系统提供技术解决方案。在加入Malers之前，他曾在多家国际高科技公司担任过包括GA Tech营销副总裁、Eldat Communication专业服务经理等多个高级营销、销售管理和专业服务职位。Luzon先生毕业于伦敦米德尔塞克斯大学，获得IT和商业信息系统学士学位。
- Ronen Luzon has served as My Size, Inc.'s Chief Executive Officer and a member of My Size, Inc.'s board of directors since September 2013. Since 2006, Mr. Luzon has additionally served as Chief Executive Officer and founder of Malers Ltd., a company in the global security solutions market which provides technological solutions for integrated communication infrastructures, security and control systems. Prior to Malers, he held several senior marketing, sales management and professional services positions in a variety of international high tech companies including VP marketing of GA Tech and Professional Services Manager of Eldat Communication. Mr. Luzon graduated from Middlesex University in London with a B.S. in IT and Business Information Systems.
- Oron Branitzky
-
Oron Branitzky自2017年3月以来一直担任我们的董事会成员。Barnitzky先生在零售技术方面有着丰富的经验。自2017年11月以来，布兰尼茨基先生一直担任Superup的全球零售业务开发，并于2007年1月至2014年12月担任PriceAB的销售与市场营销Vice President。在此之前，Branitzky先生曾担任Eldat Communication and Sarin Technologies Ltd.的市场营销与销售副总裁。自2015年1月起，Branitzky先生担任Wiseshelf Ltd.的董事会主席，从2015年5月至2016年3月，Branitzky先生担任Civalue的顾问委员会成员。Branitzky先生在耶路撒冷希伯来大学（Hebrew University of Jerusalem）获得学士学位，并在特拉维夫大学（Tel Aviv University）获得国际营销工商管理硕士学位。
Oron Branitzky has served as a member of My Size, Inc.'s board of directors since March 2017. Mr. Barnitzky has vast experience in retail technology. Since November 2017, Mr. Branitzky has served as Global Retail Business Development at Superup, and from January 2007 until December 2014 he served as Vice President of Sales and Marketing at Pricer AB. Prior to that, Mr. Branitzky has served as VP Marketing and Sales at Eldat Communication and Sarin Technologies Ltd. Since January 2015, Mr. Branitzky has served as chairman of the board of directors of WiseShelf Ltd. and from May 2015 until March 2016, Mr. Branitzky served as an advisory board member of ciValue. Mr. Branitzky received a B.S. from the Hebrew University of Jerusalem and an MBA in International Marketing from Tel Aviv University. - Oron Branitzky自2017年3月以来一直担任我们的董事会成员。Barnitzky先生在零售技术方面有着丰富的经验。自2017年11月以来，布兰尼茨基先生一直担任Superup的全球零售业务开发，并于2007年1月至2014年12月担任PriceAB的销售与市场营销Vice President。在此之前，Branitzky先生曾担任Eldat Communication and Sarin Technologies Ltd.的市场营销与销售副总裁。自2015年1月起，Branitzky先生担任Wiseshelf Ltd.的董事会主席，从2015年5月至2016年3月，Branitzky先生担任Civalue的顾问委员会成员。Branitzky先生在耶路撒冷希伯来大学（Hebrew University of Jerusalem）获得学士学位，并在特拉维夫大学（Tel Aviv University）获得国际营销工商管理硕士学位。
- Oron Branitzky has served as a member of My Size, Inc.'s board of directors since March 2017. Mr. Barnitzky has vast experience in retail technology. Since November 2017, Mr. Branitzky has served as Global Retail Business Development at Superup, and from January 2007 until December 2014 he served as Vice President of Sales and Marketing at Pricer AB. Prior to that, Mr. Branitzky has served as VP Marketing and Sales at Eldat Communication and Sarin Technologies Ltd. Since January 2015, Mr. Branitzky has served as chairman of the board of directors of WiseShelf Ltd. and from May 2015 until March 2016, Mr. Branitzky served as an advisory board member of ciValue. Mr. Branitzky received a B.S. from the Hebrew University of Jerusalem and an MBA in International Marketing from Tel Aviv University.
- Arik Kaufman
-
Arik Kaufman自2017年6月以来一直担任我们的董事会成员。Kaufman先生是一名律师，专门从事商业法，公司法和资本市场领域，自2016年起在以色列运营自己的律师事务所。他在财务报告和金融监管领域有着丰富的经验。Kaufman先生自2017年9月起担任MOR Research Applications的业务开发副总裁，自2016年11月起担任MOR Research Applications的总法律顾问。2008年12月至2016年3月，Kaufman先生是Victor Tshuva and Co.的律师。Kaufman先生在Baratz，Horn and Co.实习。此前，考夫曼先生曾担任ComverseTechnology，Inc.呼叫中心值班经理/Oracle CRM实施团队自2018年2月以来，考夫曼先生一直担任Ophectra Real Estate&Investments Ltd的董事，自2018年1月以来，考夫曼先生一直担任TechnoPlus Ventures的外部董事。此外，自2016年5月起，他担任BGI Investments1961Ltd.的董事。Kaufman先生拥有Herzliya跨学科中心的法学学士学位，并获得以色列律师资格。
Arik Kaufman has served as a member of My Size, Inc.'s board of directors since June 2017. Mr. Kaufman is an attorney specializing in the fields of commercial law, corporate law and capital markets and since 2016 runs his own law office in Israel. He has vast experience in the fields of financial reporting and financial regulation. Mr. Kaufman serves as the Chief Executive Officer of Steakholder Foods since January 2022. From September 2017 until January 2022, Mr. Kaufman served as VP Business Development of Mor Research Applications. Mr. Kaufman holds an LLB in Law from the Interdisciplinary Center, Herzliya, and is admitted to the Israeli Bar. - Arik Kaufman自2017年6月以来一直担任我们的董事会成员。Kaufman先生是一名律师，专门从事商业法，公司法和资本市场领域，自2016年起在以色列运营自己的律师事务所。他在财务报告和金融监管领域有着丰富的经验。Kaufman先生自2017年9月起担任MOR Research Applications的业务开发副总裁，自2016年11月起担任MOR Research Applications的总法律顾问。2008年12月至2016年3月，Kaufman先生是Victor Tshuva and Co.的律师。Kaufman先生在Baratz，Horn and Co.实习。此前，考夫曼先生曾担任ComverseTechnology，Inc.呼叫中心值班经理/Oracle CRM实施团队自2018年2月以来，考夫曼先生一直担任Ophectra Real Estate&Investments Ltd的董事，自2018年1月以来，考夫曼先生一直担任TechnoPlus Ventures的外部董事。此外，自2016年5月起，他担任BGI Investments1961Ltd.的董事。Kaufman先生拥有Herzliya跨学科中心的法学学士学位，并获得以色列律师资格。
- Arik Kaufman has served as a member of My Size, Inc.'s board of directors since June 2017. Mr. Kaufman is an attorney specializing in the fields of commercial law, corporate law and capital markets and since 2016 runs his own law office in Israel. He has vast experience in the fields of financial reporting and financial regulation. Mr. Kaufman serves as the Chief Executive Officer of Steakholder Foods since January 2022. From September 2017 until January 2022, Mr. Kaufman served as VP Business Development of Mor Research Applications. Mr. Kaufman holds an LLB in Law from the Interdisciplinary Center, Herzliya, and is admitted to the Israeli Bar.
高管简历
中英对照 | 中文 | 英文- Ronen Luzon
Ronen Luzon，自2013年9月起担任My Size, Inc.，Inc.的首席执行官和My Size，Inc.董事会成员。自2006年以来，Luzon先生还担任Malers Ltd.的首席执行官和创始人，该公司是全球安全解决方案市场的一家公司，为综合通信基础设施、安全和控制系统提供技术解决方案。在加入Malers之前，他曾在多家国际高科技公司担任过包括GA Tech营销副总裁、Eldat Communication专业服务经理等多个高级营销、销售管理和专业服务职位。Luzon先生毕业于伦敦米德尔塞克斯大学，获得IT和商业信息系统学士学位。
Ronen Luzon has served as My Size, Inc.'s Chief Executive Officer and a member of My Size, Inc.'s board of directors since September 2013. Since 2006, Mr. Luzon has additionally served as Chief Executive Officer and founder of Malers Ltd., a company in the global security solutions market which provides technological solutions for integrated communication infrastructures, security and control systems. Prior to Malers, he held several senior marketing, sales management and professional services positions in a variety of international high tech companies including VP marketing of GA Tech and Professional Services Manager of Eldat Communication. Mr. Luzon graduated from Middlesex University in London with a B.S. in IT and Business Information Systems.- Ronen Luzon，自2013年9月起担任My Size, Inc.，Inc.的首席执行官和My Size，Inc.董事会成员。自2006年以来，Luzon先生还担任Malers Ltd.的首席执行官和创始人，该公司是全球安全解决方案市场的一家公司，为综合通信基础设施、安全和控制系统提供技术解决方案。在加入Malers之前，他曾在多家国际高科技公司担任过包括GA Tech营销副总裁、Eldat Communication专业服务经理等多个高级营销、销售管理和专业服务职位。Luzon先生毕业于伦敦米德尔塞克斯大学，获得IT和商业信息系统学士学位。
- Ronen Luzon has served as My Size, Inc.'s Chief Executive Officer and a member of My Size, Inc.'s board of directors since September 2013. Since 2006, Mr. Luzon has additionally served as Chief Executive Officer and founder of Malers Ltd., a company in the global security solutions market which provides technological solutions for integrated communication infrastructures, security and control systems. Prior to Malers, he held several senior marketing, sales management and professional services positions in a variety of international high tech companies including VP marketing of GA Tech and Professional Services Manager of Eldat Communication. Mr. Luzon graduated from Middlesex University in London with a B.S. in IT and Business Information Systems.
- Billy Pardo
Billy Pardo，自2014年5月起担任My Size, Inc.首席产品官，自2019年4月起担任首席运营官。从2010年4月至2013年8月，Pardo女士担任Fourier Education管理高级总监。她的专长领域包括以各种方法推出从概念到成功交付的产品，包括傅立叶教育屡获殊荣的爱因斯坦Science平板电脑。在此之前，Pardo女士曾担任多个产品管理职位，包括：Time to Know的项目经理、RiT Technologies的产品营销经理、Pricer AB的产品经理和Pricer AB的研发团队负责人。Pardo女士此前曾在Eldat Communication Ltd.担任软件工程师，并在NICE Systems担任QA工程师。Pardo女士获得了The Interdisciplinary Center的MBA学位和The Academic College of Tel-Aviv-Yaffo的计算机科学学士学位。
Billy Pardo has served as My Size, Inc.'s Chief Product Officer since May 2014 and Chief Operating Officer since April 2019. From April 2010 until August 2013, Ms. Pardo served as Senior Director of Product Management of Fourier Education. Among her areas of expertise are launching products from concept to successful delivery in various methodologies, including Fourier Education's award winning einstein Science Tablet. Prior to that Ms. Pardo served in various product management positions including, Project Manager of Time to Know, Product Marketing Manager of RiT Technologies, Product Manager of Pricer AB and R&D Team Leader at Pricer AB. Ms. Pardo previously served as Software Engineer at Eldat Communication Ltd., and QA Engineer at NICE Systems. Ms. Pardo received an MBA from The Interdisciplinary Center and a B.A. in Computer Science from The Academic College of Tel Aviv Yaffo.- Billy Pardo，自2014年5月起担任My Size, Inc.首席产品官，自2019年4月起担任首席运营官。从2010年4月至2013年8月，Pardo女士担任Fourier Education管理高级总监。她的专长领域包括以各种方法推出从概念到成功交付的产品，包括傅立叶教育屡获殊荣的爱因斯坦Science平板电脑。在此之前，Pardo女士曾担任多个产品管理职位，包括：Time to Know的项目经理、RiT Technologies的产品营销经理、Pricer AB的产品经理和Pricer AB的研发团队负责人。Pardo女士此前曾在Eldat Communication Ltd.担任软件工程师，并在NICE Systems担任QA工程师。Pardo女士获得了The Interdisciplinary Center的MBA学位和The Academic College of Tel-Aviv-Yaffo的计算机科学学士学位。
- Billy Pardo has served as My Size, Inc.'s Chief Product Officer since May 2014 and Chief Operating Officer since April 2019. From April 2010 until August 2013, Ms. Pardo served as Senior Director of Product Management of Fourier Education. Among her areas of expertise are launching products from concept to successful delivery in various methodologies, including Fourier Education's award winning einstein Science Tablet. Prior to that Ms. Pardo served in various product management positions including, Project Manager of Time to Know, Product Marketing Manager of RiT Technologies, Product Manager of Pricer AB and R&D Team Leader at Pricer AB. Ms. Pardo previously served as Software Engineer at Eldat Communication Ltd., and QA Engineer at NICE Systems. Ms. Pardo received an MBA from The Interdisciplinary Center and a B.A. in Computer Science from The Academic College of Tel Aviv Yaffo.
- Oren Elmaliah
Oren Elmaliah，自2017年5月起担任我们的董事会成员。2015年9月，Oren Elmaliah成立了会计团队IL，并从那时起担任客户经理。会计团队IL是一家为在以色列和国外交易的上市公司提供财务咨询和服务的公司。自2017年2月起，Elmaliah先生担任Bioblast Pharma的财务总监，自2017年1月起，他担任Presstek Israel的首席财务官。此外，Elmaliah先生自2015年9月起担任LG Electronics Israel的以色列当局报告官，自2015年9月起担任Chiasma的当地财务报告顾问。Elmaliah从2011年7月到2015年8月担任CFO Director Ltd注册会计师和财务总监，从2010年6月到2011年7月担任RSM International Limited风险管理顾问。Elmaliah先生拥有会计/经济学学士学位和硕士学位。以色列特拉维夫大学（Tel Aviv University）金融/会计学士学位。他是以色列有执照的注册会计师。
Oren Elmaliah served as a member of My Size, Inc.'s board of directors since May 2017 until March 2025. Effective April 1, 2025, Mr. Elmaliah was appointed as My Size, Inc.'s Chief Financial Officer. In September 2015, Oren Elmaliah founded Accounting Team IL and has acted as Account Manager since then. Accounting Team IL is a financial consultancy and service provider to public companies traded in Israel and abroad. Since February 2017, Mr. Elmaliah has served as controller of Enlivex Therapeutics Ltd., and since January 2017 he has served as Chief Financial Officer of Presstek Israel. In addition, since September 2015, Mr. Elmaliah has served as an Israel Authorities Reporting Officer of LG Electronics Israel and since September 2015 he has served as Local Financial Report Consultant of Chiasma. From July 2011 until August 2015, Mr. Elmaliah served as CPA, Financial Director of CFO Director Ltd and from June 2010 until July 2011 he served as Risk Management Consultant of RSM International Limited. Mr. Elmaliah holds a B.A. in Accounting/Economics and a Msc. in Finance/Accounting from Tel Aviv University, Israel. He is a licensed Certified Public Accountant in Israel.- Oren Elmaliah，自2017年5月起担任我们的董事会成员。2015年9月，Oren Elmaliah成立了会计团队IL，并从那时起担任客户经理。会计团队IL是一家为在以色列和国外交易的上市公司提供财务咨询和服务的公司。自2017年2月起，Elmaliah先生担任Bioblast Pharma的财务总监，自2017年1月起，他担任Presstek Israel的首席财务官。此外，Elmaliah先生自2015年9月起担任LG Electronics Israel的以色列当局报告官，自2015年9月起担任Chiasma的当地财务报告顾问。Elmaliah从2011年7月到2015年8月担任CFO Director Ltd注册会计师和财务总监，从2010年6月到2011年7月担任RSM International Limited风险管理顾问。Elmaliah先生拥有会计/经济学学士学位和硕士学位。以色列特拉维夫大学（Tel Aviv University）金融/会计学士学位。他是以色列有执照的注册会计师。
- Oren Elmaliah served as a member of My Size, Inc.'s board of directors since May 2017 until March 2025. Effective April 1, 2025, Mr. Elmaliah was appointed as My Size, Inc.'s Chief Financial Officer. In September 2015, Oren Elmaliah founded Accounting Team IL and has acted as Account Manager since then. Accounting Team IL is a financial consultancy and service provider to public companies traded in Israel and abroad. Since February 2017, Mr. Elmaliah has served as controller of Enlivex Therapeutics Ltd., and since January 2017 he has served as Chief Financial Officer of Presstek Israel. In addition, since September 2015, Mr. Elmaliah has served as an Israel Authorities Reporting Officer of LG Electronics Israel and since September 2015 he has served as Local Financial Report Consultant of Chiasma. From July 2011 until August 2015, Mr. Elmaliah served as CPA, Financial Director of CFO Director Ltd and from June 2010 until July 2011 he served as Risk Management Consultant of RSM International Limited. Mr. Elmaliah holds a B.A. in Accounting/Economics and a Msc. in Finance/Accounting from Tel Aviv University, Israel. He is a licensed Certified Public Accountant in Israel.
- Borja Cembrero Saralegui
Borja Cembrero Saralegui，自2025年5月起担任My Size, Inc.首席增长官。Cembrero先生在时尚科技创新、战略增长和零售领域的人工智能部署方面有着良好的业绩记录，在创业、营销和业务发展方面拥有十多年的经验。自2022年以来，Cembrero先生担任My Size的全资子公司Naiz Bespoke Technologies，S.L.（“Naiz Fit”）的首席执行官，该公司是他在2017年与他人共同创立的公司，之后公司于2022年被My Size收购。在担任这一职务之前，2016年至2017年，Cembrero先生与他人共同创立了Teem Players，这是一个数字体育平台，将体育迷与他们选择的城市的球员联系起来。2015年至2016年，Cembrero先生在GrowPro Experience担任业务发展职务，这是一个为想要在国外生活、学习和工作的人们提供免费整体咨询的数字平台。Cembrero先生拥有Deusto商学院（西班牙）的工商管理和法律双学位，并作为该机构享有盛誉的荣誉课程的一部分毕业，还曾担任Deusto商学院的国际营销教授。他还通过Mondragon大学和Fundaci ó n EDE的联合项目完成了领导力、人员管理和组织效率方面的高管培训。
Borja Cembrero Saralegui has served as My Size, Inc.'s Chief Growth Officer since May 2025. Mr. Cembrero has a proven track record in fashion tech innovation, strategic growth, and AI deployment in retail and has more than a decade of experience across entrepreneurship, marketing, and business development. Since 2022, Mr. Cembrero has served as the chief executive officer of My Size, Inc.'s Size's wholly owned subsidiary, Naiz Bespoke Technologies, S.L. ("Naiz Fit"), a company he co founded in 2017 prior to its acquisition by My Size, Inc.'s Size in 2022. Prior to this role, from 2016 to 2017, Mr. Cembrero co founded Teem Players, a digital sports platform that connect sports fans to players in their city of choice, and from 2015 to 2016, Mr. Cembrero served in a business development role at GrowPro Experience, a digital platform that offers free integral advisory to people who want to live, study and work abroad. Mr. Cembrero holds a double degree in Business Administration and Law from Deusto Business School (Spain), where he graduated as part of the institution's prestigious Honors Program, and has also been a professor of international marketing at Deusto Business School. He also completed executive training in Leadership, People Management, and Organizational Efficiency through a joint program by Mondragon University and Fundación EDE.- Borja Cembrero Saralegui，自2025年5月起担任My Size, Inc.首席增长官。Cembrero先生在时尚科技创新、战略增长和零售领域的人工智能部署方面有着良好的业绩记录，在创业、营销和业务发展方面拥有十多年的经验。自2022年以来，Cembrero先生担任My Size的全资子公司Naiz Bespoke Technologies，S.L.（“Naiz Fit”）的首席执行官，该公司是他在2017年与他人共同创立的公司，之后公司于2022年被My Size收购。在担任这一职务之前，2016年至2017年，Cembrero先生与他人共同创立了Teem Players，这是一个数字体育平台，将体育迷与他们选择的城市的球员联系起来。2015年至2016年，Cembrero先生在GrowPro Experience担任业务发展职务，这是一个为想要在国外生活、学习和工作的人们提供免费整体咨询的数字平台。Cembrero先生拥有Deusto商学院（西班牙）的工商管理和法律双学位，并作为该机构享有盛誉的荣誉课程的一部分毕业，还曾担任Deusto商学院的国际营销教授。他还通过Mondragon大学和Fundaci ó n EDE的联合项目完成了领导力、人员管理和组织效率方面的高管培训。
- Borja Cembrero Saralegui has served as My Size, Inc.'s Chief Growth Officer since May 2025. Mr. Cembrero has a proven track record in fashion tech innovation, strategic growth, and AI deployment in retail and has more than a decade of experience across entrepreneurship, marketing, and business development. Since 2022, Mr. Cembrero has served as the chief executive officer of My Size, Inc.'s Size's wholly owned subsidiary, Naiz Bespoke Technologies, S.L. ("Naiz Fit"), a company he co founded in 2017 prior to its acquisition by My Size, Inc.'s Size in 2022. Prior to this role, from 2016 to 2017, Mr. Cembrero co founded Teem Players, a digital sports platform that connect sports fans to players in their city of choice, and from 2015 to 2016, Mr. Cembrero served in a business development role at GrowPro Experience, a digital platform that offers free integral advisory to people who want to live, study and work abroad. Mr. Cembrero holds a double degree in Business Administration and Law from Deusto Business School (Spain), where he graduated as part of the institution's prestigious Honors Program, and has also been a professor of international marketing at Deusto Business School. He also completed executive training in Leadership, People Management, and Organizational Efficiency through a joint program by Mondragon University and Fundación EDE.